| 1 |
Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery, Masuda M, et al. Thoracic and cardiovascular surgery in Japan during 2015 : annual report by the Japanese Association for Thoracic Surgery[J]. Gen Thorac Cardiovasc Surg, 2018，66(10): 581-615.
|
| 2 |
Takeuchi H, Miyata H, Ozawa S, et al. Comparison of short-term outcomes between open and minimally invasive esophagectomy for esophageal cancer using a nationwide database in Japan[J]. Ann Surg Oncol, 2017，24(7): 1821-1827.
|
| 3 |
Kataoka K, Takeuchi H, Mizusawa J, et al. A randomized Phase Ⅲ trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409[J]. Jpn J Clin Oncol, 2016，46(2): 174-177.
|
| 4 |
Kakegawa T, Yamana H, Fujita H. Cervical lymph node dissection during radical esophagectomy[J]．Geka Shinryo (Surg Diagn Treat), 1986，28: 523-528.
|
| 5 |
Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy[J]. Ann Surg, 1995，222(5): 654-662.
|
| 6 |
Isono K, Onoda S, Okuyama K, et al. The signifificance ofcervical lymph nodes dissection in radical operation of esophageal cancer[J]. Geka Shinryo (Surg Diagn Treat), 1986，28: 529-535.
|
| 7 |
Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer[J]. Oncology, 1991，48(5): 411-420.
|
| 8 |
Muto T, Hasegawa M, Katayanagi N, et al.Appraisal of cervical lymph node dissection for thoracic esophageal carcinoma[J]. Geka Shinryo (Surg Diagn Treat)，1986，28: 536-540.
|
| 1 |
Tsurumaru M, Akiyama H, Ono Y, et al. The signifificance of cervical lymph nodes dissection in radical operation of esophageal cancer[J]. Geka Shinryo (Surg Diagn Treat), 1986，28: 555-560.
|
| 10 |
Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus[J]. Ann Surg, 1994，220(3): 364-373.
|
| 11 |
Kato H, Watanabe H, Tachimori Y, et al. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma[J]. Ann Thorac Surg, 1991，51(6): 931-935.
|
| 12 |
Suda K, Ishida Y, Kawamura Y, et al. Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes[J]. World J Surg, 2012，36(7): 1608-1616.
|
| 13 |
Fujiwara H, Shiozaki A, Konishi H, et al. Perioperative outcomes of single-port mediastinoscope-assisted transhiatal esophagectomy for thoracic esophageal cancer[J]. Dis Esophagus, 2017，30(10): 1-8.
|
| 14 |
Nakamura K, Kato K, Igaki H, et al. Three-arm phase Ⅲ trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study)[J]. Jpn J Clin Oncol, 2013，43(7): 752-755.
|
| 15 |
Kitagawa Y, Uno T, Oyama T，et al. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2[J]. Esophagus，2019；16(1): 1-24.
|
| 16 |
Nishi M, Kajisa T, Akune T, et al. Cardia cancer-proposal of cancer in the esophagogastric junction[J]. Geka Shinryo (Surg Diagn Treat)，1973，15: 1328-1338.
|
| 17 |
Kurokawa Y, Takeuchi H, Doki Y, et al. Mapping of lymph node metastasis from esophagogastric junction tumors: a prospective nationwide multicenter study[J]. Ann Surg, 2019 Aug 8. DOI: 10.1097/SLA.0000000000003499. |
| 18 |
Tachimori Y, Ozawa S, Numasaki H, et al. Supraclavicular node metastasis from thoracic esophageal carcinoma: a surgical series from a Japanese multi-institutional nationwide registry of esophageal cancer[J]. J Thorac Cardiovasc Surg, 2014，148(4): 1224-1229.
|
| 19 |
Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 11th Edition: partⅠ[J]. Esophagus, 2017，14(1): 1-36.
|